Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Ventromedial hypothalamic nucleus neuronal nitric oxide knockdown effects on GABAergic neuron metabolic sensor and transmitter marker gene expression in the male rat.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100966986 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2202 (Electronic) Linking ISSN: 14712202 NLM ISO Abbreviation: BMC Neurosci Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London: BioMed Central, [2000-
    • الموضوع:
    • نبذة مختصرة :
      Competing Interests: Declarations. Ethical approval: Studies performed here were approved by the University of Louisiana Monroe Institutional Animal Care and Use Committee, reference no. 19AUG-KPB-01, in accordance with the National Institutes of Health (NIH) Guide for Care and Use of Laboratory Animals, 8th Edition. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
      The diffusible gas nitric oxide (NO) and amino acid γ-gamma-aminobutyric acid (GABA) exert contrary effects on glucose counterregulation in the male rat, but how these neurochemical signals integrate within ventromedial hypothalamic nucleus (VMN) neural circuitries remains unclear. Female rat dorsomedial (VMNdm) and ventrolateral (VMNvl) GABAergic neurons express neuronal nitric oxide synthase (nNOS) mRNA; notably these subpopulations exhibit dissimilar nNOS transcriptional responses to insulin-induced hypoglycemia (IIH). Here, nNOS gene knockdown tools were used to examine whether one or both VMN GABA neuron groups may be a target for nitrergic control of basal and hypoglycemic counterregulatory hormone secretion in the male. Data show that VMN nNOS gene knockdown respectively up- or down-regulated counterregulatory hormone profiles in eu- versus hypoglycemic male rats. Single-cell multiplex qPCR analysis of laser-catapult-microdissected GABA neurons showed that IIH elevated nNOS gene expression in GABA neurons from each VMN division, yet nNOS siRNA pretreatment attenuated distinctive IIH-associated transmitter marker gene expression patterns in VMNdm versus VMNvl GABAergic neurons. nNOS gene silencing had similar effects on glucokinase and glucose transporter gene responses to IIH in each GABA neuron subpopulation but elicited division-specific effects on mRNA encoding 5-AMP-activated protein kinase (AMPK) alpha/catalytic subunits and the lactate membrane receptor GPR81/HCAR1. Current findings provide original evidence that VMN NO may impose bi-directional, glucose status-contingent control of counterregulatory hormone outflow in the male rat. Data moreover imply that during IIH, NO may control distinctive sources of metabolic sensory regulatory stimuli in VMNdm versus VMNvl GABA neurons and may shape unique counterregulation-controlling neurochemical transmission by each cell population.
      (© 2025. The Author(s).)
    • References:
      Mol Cell Neurosci. 2019 Mar;95:51-58. (PMID: 30660767)
      J Chem Neuroanat. 2022 Oct;124:102132. (PMID: 35772680)
      Brain Res Bull. 2020 Apr;157:41-50. (PMID: 31981674)
      J Neurochem. 1996 Nov;67(5):1982-91. (PMID: 8863504)
      Front Neuroendocrinol. 2010 Jan;31(1):32-43. (PMID: 19836412)
      Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62. (PMID: 22436748)
      Neuroendocrinology. 2024;114(1):25-41. (PMID: 37699381)
      Am J Physiol Regul Integr Comp Physiol. 2023 Jan 1;324(1):R20-R34. (PMID: 36409024)
      Diabetes. 2017 Jul;66(7):1979-1989. (PMID: 28416628)
      Front Cell Neurosci. 2014 Dec 17;8:428. (PMID: 25565962)
      Br J Nutr. 2003 Jan;89(1):3-9. (PMID: 12568659)
      Methods. 2001 Dec;25(4):402-8. (PMID: 11846609)
      Pflugers Arch. 2020 Sep;472(9):1155-1175. (PMID: 32591905)
      Antioxid Redox Signal. 2011 Feb 1;14(3):505-17. (PMID: 20518706)
      Cell. 2019 Oct 17;179(3):713-728.e17. (PMID: 31626771)
      Perspect Dev Neurobiol. 1998;5(2-3):119-29. (PMID: 9777630)
      Curr Opin Neurobiol. 2009 Jun;19(3):305-10. (PMID: 19375301)
      Neurochem Res. 2024 Dec;49(12):3367-3382. (PMID: 39306597)
      J Chem Neuroanat. 2022 Jul;122:102102. (PMID: 35483611)
      Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E141-5. (PMID: 20009031)
      J Mol Neurosci. 2020 May;70(5):647-658. (PMID: 31925707)
      J Neurochem. 2000 May;74(5):1848-57. (PMID: 10800927)
      Biochim Biophys Acta Mol Basis Dis. 2019 Aug 1;1865(8):1949-1967. (PMID: 30500433)
      Expert Rev Clin Pharmacol. 2017 Apr;10(4):409-428. (PMID: 28276776)
      Neuron. 2007 Jun 21;54(6):889-903. (PMID: 17582330)
      IBRO Neurosci Rep. 2022 Jun 06;13:38-46. (PMID: 35711244)
      Mol Aspects Med. 2013 Apr-Jun;34(2-3):121-38. (PMID: 23506862)
      Neuroscience. 2019 Jul 15;411:211-221. (PMID: 31085279)
      Physiology (Bethesda). 2014 Sep;29(5):314-24. (PMID: 25180261)
      Trends Cell Biol. 2016 Mar;26(3):190-201. (PMID: 26616193)
      ASN Neuro. 2024;16(1):2368382. (PMID: 39024550)
      Sci Rep. 2021 Mar 16;11(1):6079. (PMID: 33727605)
      Neuroscience. 2023 Oct 1;529:73-87. (PMID: 37572878)
      FEBS Lett. 1996 Nov 18;397(2-3):347-51. (PMID: 8955377)
      Diabetes. 2010 Feb;59(2):519-28. (PMID: 19934009)
      J Comp Neurol. 2013 Apr 15;521(6):1268-88. (PMID: 22987798)
      Sci Rep. 2024 Jun 20;14(1):14220. (PMID: 38902332)
      Front Physiol. 2019 Mar 06;10:148. (PMID: 30949058)
      Forensic Sci Int. 2004 Dec 16;146(2-3):105-10. (PMID: 15542270)
      Forensic Sci Med Pathol. 2024 Sep;20(3):810-822. (PMID: 37466819)
      Am J Physiol Regul Integr Comp Physiol. 2021 Jun 1;320(6):R791-R799. (PMID: 33825506)
      Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12911-6. (PMID: 10536022)
      Arch Pharm Res. 2019 Dec;42(12):1031-1039. (PMID: 31786745)
    • Grant Information:
      R01 DK109382 United States DK NIDDK NIH HHS; DK 109382 United States DK NIDDK NIH HHS
    • Contributed Indexing:
      Keywords: AMPK; GABA neuron; GAD1/2; Glucagon; Glucokinase; nNOS siRNA
    • الرقم المعرف:
      EC 1.14.13.39 (Nitric Oxide Synthase Type I)
      56-12-2 (gamma-Aminobutyric Acid)
      31C4KY9ESH (Nitric Oxide)
      0 (Insulin)
    • الموضوع:
      Date Created: 20250224 Date Completed: 20250509 Latest Revision: 20250509
    • الموضوع:
      20250510
    • الرقم المعرف:
      PMC11853586
    • الرقم المعرف:
      10.1186/s12868-025-00940-0
    • الرقم المعرف:
      39994513